Ana Cristina Riestra

Onkologikoa, Universidad de Deusto

Papers

2

Total Citations

14

H-Index

2

About

Ana Cristina Riestra is a leading researcher in hospital pharmacy automation, with a primary focus on the safe and efficient robotic compounding of hazardous medicinal products, particularly antineoplastic agents. Her work directly addresses critical challenges in occupational safety and operational productivity within oncology pharmacy settings. Riestra’s most cited study, “Robotic chemotherapy compounding: A multicenter productivity approach” (2021, 12 citations), provides a foundational analysis of the KIRO Oncology robot’s performance across three hospitals, identifying key factors that predict and optimize automated compounding time. This multicenter approach offers actionable insights for health systems seeking to implement robotics. Her more recent work, “Monitoring of occupational exposure to hazardous medicinal products in robotic compounding” (2025, 2 citations), breaks new ground by rigorously assessing surface contamination levels on ready-to-use preparations from robotic systems, demonstrating a commitment to validating the safety benefits of automation. By bridging the gap between technological implementation and rigorous safety monitoring, Riestra’s research is instrumental for hospital pharmacies aiming to enhance both staff protection and workflow efficiency in the handling of hazardous drugs.

Research Focus

Key Achievements

2
H-Index
2
Papers
14
Total Citations
7
Avg Citations/Paper
🏆 Most Cited Paper
Robotic chemotherapy compounding: A multicenter productivity approach
12 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 15
🏛 Institutions: Onkologikoa, Universidad de Deusto

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago